Back to top
more

Accelerate Diagnostics (AXDX)

(Delayed Data from NSDQ)

$0.89 USD

0.89
286

-0.04 (-4.61%)

Updated Apr 25, 2024 09:30 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Becton (BDX) with FlowJo to Provide Cloud Platform Services

Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has entered into an agreement with FlowJo, LLC.

    Mead Johnson-Reckitt Move to Merge, Deal Closes on Jun 15

    Mead Johnson Nutrition Company (MJN) and Reckitt Benckiser have cleared the final regulatory hurdle of their impending merger.

      PetMed Express' New Order Sales Increase, Competition Rife

      On Jun 12, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).

        Quest Diagnostics to Buy 2 Labs, Grow in Oncology Space

        Quest Diagnostics (DGX) recently announced agreements to acquire two laboratory businesses in Lewisville, Texas, namely Med Fusion and Clear Point.

          Phibro Animal Health (PAHC) Rides High on Solid Prospects

          On Jun 12, we issued an updated research report on NJ-based Phibro Animal Health Corporation (PAHC) ??? a leading global diversified animal health and mineral nutrition company.

            Luminex's (LMNX) VERIGENE Panels Receive Approval in Japan

            Luminex Corporation (LMNX) recently announced that Japan's Central Social Insurance Medical Council has approved to provide reimbursement for VERIGENE assays.

              Will Walgreens-Rite Aid Deal Fall Flat on FTC Blockade?

              Walgreens Boots Alliance, Inc. (WBA) stock took a marginal hit of 0.6% on Friday's close, following the news breakout that the FTC is blocking the impending Rite Aid merger deal.

                Masimo (MASI) Presents Utility Study of Oxygen Reserve Index

                Masimo Corporation (MASI) recently announced data from its study evaluating the potential clinical utility of Masimo Oxygen Reserve Index.

                  NuVasive (NUVA) at 52-Week High: What's Driving the Stock?

                  Share price of NuVasive, Inc. (NUVA) scaled a new 52-week high of $81.06 on Jun 9, eventually closing a bit lower at $79.13.

                    Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3

                    Share price of Cardiovascular Systems, Inc. (CSII) scaled a new 52-week high of $32.68 on Jun 9, eventually closing a bit lower at $30.93.

                      Medtronic Launches MiniMed 670G to Better Manage Diabetes

                      Medtronic plc (MDT) commercially launched MiniMed 670G system, a Hybrid Closed Loop insulin delivery system for Type I diabetic patients.

                        Invacare (IVC) Prices $105 Million Convertible Senior Notes

                        Invacare Corporation (IVC) recently announced that it has priced convertible senior notes worth $105 million.

                          CVS Health Gains on Pharmacy Services, Strategic Buyouts

                          On Jun 8, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).

                            Hologic Wins FDA Approval for Genius 3D Mammography Exam

                            Hologic, Inc. (HOLX) continues to expand its Breast and Skeletal Health business through innovation and product development.

                              Zimmer Biomet Rides on Spine Business, Knee Challenges Stay

                              On Jun 6, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH).

                                Bruker Grows on NMR & Nano Businesses amid Several Odds

                                On Jun 6, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR), a manufacturer of proprietary life science and materials research systems.

                                  Boston Scientific Wins CE Mark for Vercise Gevia DBS System (revised)

                                  Generally, DBS therapy is a surgical procedure of placing a device that stimulates specific areas in the brain using electrical signals.

                                    Cardiovascular Systems Innovation On Track, Competition Rife

                                    On Jun 6, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).

                                      Medtronic SureTune3 Obtains Health Canada License for DBS

                                      Medtronic plc (MDT) recently announced the receipt of Health Canada license for SureTune 3 software for deep brain stimulation (DBS).

                                        Boston Scientific Wins CE Mark for Vercise Gevia DBS System

                                        Boston Scientific Corporation (BSX) recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System.

                                          HealthEquity (HQY) Q1 Earnings and Revenues Beat Estimates

                                          HealthEquity Inc (HQY) reported earnings of 19 cents per share in the first quarter of fiscal 2018, higher than the Zacks Consensus Estimate of 16 cents.

                                            Amedisys (AMED) Prospects Impressive Amid Tough Competition

                                            On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).

                                              Abiomed (ABMD) at 52-Week High: What's Driving the Stock?

                                              Share price of Abiomed, Inc. (ABMD), scaled a new 52-week high of $142.95 on Jun 5, eventually closing a bit lower at $141.81.

                                                Cerner (CERN) to Develop Electronic Health Records System

                                                Cerner Corp (CERN) recently announced that it has been chosen by the U.S. Department of Veterans Affairs to develop an electronic health record (EHR) system.

                                                  Edwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval

                                                  Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).